Published in Gene Therapy Weekly, July 25th, 2002
Members of an international research team have issued the results of using a p53 gene replacement therapy known as SCH 58500 to treat women with recurrent ovarian cancer in a set of reports published in the July 2002 issue of Cancer Gene Therapy. According to these investigators, long-term follow-up of treated patients suggests that multiple doses of the therapy tends to extend survival better than single-dose therapy does in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly